OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) major shareholder Squadron Capital Llc sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $25.75, for a total value of $103,000.00. Following the completion of the transaction, the insider directly owned 6,897,764 shares of the company’s stock, valued at $177,617,423. This represents a 0.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Squadron Capital Llc also recently made the following trade(s):
- On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.28, for a total transaction of $437,040.00.
- On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.74, for a total transaction of $403,262.00.
OrthoPediatrics Trading Down 1.9%
Shares of KIDS stock traded down $0.47 during trading hours on Wednesday, hitting $24.03. 169,608 shares of the company’s stock traded hands, compared to its average volume of 171,545. The stock’s 50 day simple moving average is $21.11 and its 200 day simple moving average is $18.53. The stock has a market cap of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the company. Needham & Company LLC increased their price target on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Truist Financial set a $22.00 price target on OrthoPediatrics in a research note on Wednesday, August 5th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $26.44.
Read Our Latest Research Report on OrthoPediatrics
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in KIDS. Russell Investments Group Ltd. boosted its holdings in OrthoPediatrics by 433.1% in the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after acquiring an additional 1,139 shares in the last quarter. Legal & General Group Plc acquired a new position in shares of OrthoPediatrics during the second quarter worth approximately $34,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of OrthoPediatrics by 5,226.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after purchasing an additional 2,561 shares in the last quarter. Caption Management LLC acquired a new stake in OrthoPediatrics in the 3rd quarter valued at $54,000. Finally, BNP Paribas Financial Markets increased its stake in OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock valued at $61,000 after purchasing an additional 1,235 shares in the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.
About OrthoPediatrics
OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.
The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.
Featured Articles
- Five stocks we like better than OrthoPediatrics
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
